Skip to Content

'
Don L. Gibbons, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Assistant Professor, Department of Molecular and Cellular Oncology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: 432
Houston, TX 77030
Room Number: FC9.2038
Phone: 713-792-6363

Education & Training

Degree-Granting Education

2004 Albert Einstein College of Medicine, Bronx, NY, MD, Medicine
2004 Albert Einstein College of Medicine, Bronx, NY, PHD, Cell Biology
1999 Albert Einstein College of Medicine, Bronx, NY, MS, Cell Biology
1996 University of Texas Health Science Center, San Antonio, TX, MS, Biochemistry
1993 Harvard University, Cambridge, MA, BA, Cum Laude, Biochemistry

Postgraduate Training

7/2007-6/2009 Research Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Jonathan Kurie
7/2006-6/2009 Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston,, TX, Dr. Robert Wolff
6/2004-6/2006 Clinical Residency, MeRIT Scholars Program, Internal Medicine, Baylor College of Medicine, Houston,, TX, Dr. Amir Halevy

Experience/Service

Academic Appointments

Instructor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009-2010

Selected Publications

Abstracts
1. Pricl S, Gibbons DL, Posocco P, Laurini E, Fermeglia M, Kantarjian H, Talpaz M, Cortes J, Donato N, Quintas-Cardama A. In Silico Modeling of Sensitivity to Novel Tyrosine Kinase Inhibitors of Highly Resistant Single-Point Mutant and Polymutant BCR-ABL1 Proteins. American Society of Hematology, 2010.
2. Pricl S, Gibbons DL, Posocco P, Laurini E, Fermaglia M, Kantarjian HM, Talpaz M, Cortes J, Donato N, Quintas-Cardama. The Novel BCR-ABL1 V304D Mutation Induces Pan-Tyrosine Kinase Inhibitor Resistance by a Unique Kinase Lateral Escape Mechanism and is Associated with very Poor Prognosis in Patients with Chronic Myeloid Leukemia. American Society of Hematology, 2010.

Book Chapters
1. Gibbons DL, Rizvi ZH, Kurie JM. MicroRNAs in Cancer Translational Research. In: The Role of microRNAs in Lung Cancer Development, Progression and Metastasis, 1st. Springer Press, 557, 2011. ISBN: 978-94-007-0297-4.
2. Gibbons DL, Pisters KMW, Johnson FM. Non-Small Cell Lung Cancer. In: The MD Anderson Manual of Clinical Oncology. Ed(s) Kantarjian HN, Koller CM, Wolff R, 2011.

Grant & Contract Support

Title: microRNA-200 Regulation in Epithelial Maintenance and Metastasis Suppression
Funding Source: The PEW Charitable Trusts
Role: Principal Investigator
Duration: 7/1/2011 - 6/30/2015

Last updated: 3/8/2013